Abstract
This study assessed the Burden and Transmission Dynamics of Toxoplasmosis in Relation to Congenital Diseases among Pregnant Women in the Asante Mampong Municipality of Ghana. A cross-sectional design was used to recruit 201 pregnant women from six health facilities conveniently. Participants’ socio-demographics, clinical and environmental data were collected using a structured questionnaire. Using 2ml of blood, T. gondii seroprevalence was determined by the TOXO IgG/IgM Rapid Test Cassette. Data was analyzed using descriptive and logistic regression analysis with SPSS version 27 to determine the prevalence and associations of T. gondii infection with other variables, respectively. The seroprevalence of T. gondii was 49.75%, of which 40.30%, 2.49%, and 6.97% tested positive for IgG, IgM, and IgG/IgM, respectively. Co-infection of toxoplasmosis with viral hepatitis B, HIV, and syphilis rates were 15%, 1%, and 4%, respectively and were not risk factors for T. gondii transmission. Educational level and residential status were associated with toxoplasmosis [p<0.05]. Participants with higher education had a reduced risk of T. gondii infections compared to a lower level of education [AOR= 0.39 (0.13, 0.99) p=0.049]. Similarly, those residing in peri-urban and urban areas had a reduced risk of infection with T. gondii [AOR= 0.13 (0.02, 0.7) p=0.02] and [AOR= 0.10 (0.02, 0.78) p=0.03], respectively. Backyard animals with extensive and semi-intensive systems, without veterinary care, and contact with animal droppings and water sources were significant risk factors for T. gondii infection [p<0.05]. Miscarriage was associated with T. gondii infection [p<0.05]. The burden of T. gondii infection was high among the study population, with the risk of mother-child transmission. Level of education, residence, backyard animal farms, hygiene practices, water sources and quality were risk factors for T. gondii infection. Toxoplasmosis is a risk factor for miscarriage, and therefore, integrating it into ANC routine screening could improve pregnancy outcomes.
Author Summary Toxoplasmosis, caused by the parasite Toxoplasma gondii, is a significant health problem, particularly for pregnant women due to its potential to cause severe congenital diseases. This study examined the prevalence and risk factors of toxoplasmosis among pregnant women in the Asante Mampong Municipality of Ghana. Nearly half of the study participants tested positive for T. gondii, showing a substantial public health burden. The analysis identified several contributing factors, including lower educational levels, rural residency, backyard farming practices, and poor water sources, all of which increased susceptibility to infection. Miscarriage was also associated with toxoplasmosis. The study demonstrates the need for integrating routine toxoplasmosis screening into antenatal care to mitigate adverse pregnancy outcomes and reduce transmission risks. This research provides vital data that could inform public health policies to improve maternal and neonatal health in Ghana.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
1. Committee on Human Research and Publication Ethics, Kwame Nkrumah University of Science and Technology. 2. Ashanti Regional Health Directorate, Ghana Health Service.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.